|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| Nabi Biopharmaceuticals - SWOT Analysis |
|
|
|
|
€ 100,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Mai 2007 |
Taille du document : |
23 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 51 pages | Septembre 2008 | Anglais
|
|
|
| Main
focus: |
infectious diseases,infectious disease,vaccine,...,...
|
| Research
focus: |
industry structure,market segmentation, |
| Geographic
focus: |
usa,india,united kingdom,kenya,indonesia,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Chinese Markets for Biotechnology
153 pages | Janvier 2002 |
China's demand for biotechnology has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic t |
2 835,00 €
|
| |
| |
The Pharmacogenomics Outlook
174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development.
By identifying differenc |
955,00 €
|
| |
| |
Nanotechnology: Emerging Trends
30 pages | Avril 2003 |
Recently, nanotechnology has become extremely popular and is used to describe many types of research where the characteristic dimensions are less than about 1,000 nanometers.
Nanotechnology also pr |
550,00 €
|
| |
| |
Antisense Therapeutics IRCD
pages | Juin 2001 |
Antisense molecules are stretches of single-stranded nucleic acid that target and bind with a specific mRNA, interfering with and even preventing the translation or over-expression of the protein |
1 026,17 €
|
| |
| |
03-052B: The DNA Purification Market: Keys to Success for Commercial Kit Suppliers
152 pages | Octobre 2003 |
This report is designed to help life science product managers understand customers in the DNA purification market and the factors that drive their purchasing behavior |
1 280,00 €
|
| |
| |
04-036: Building Brand Equity in the Molecular Biology Market
366 pages | Juin 2004 |
This report is designed to help marketers understand what factors play into a scientist’s decision to choose one supplier over another when purchasing molecular biology products |
1 840,00 €
|
| |
| |
NanoBioTechnology: Trends and Technological Developments
18 pages | Février 2003 |
Nanobiotechnology is being projected as a great scientific and technological opportunity for the Bio world.
It is widely recognized as one of the most beneficial areas of nanotechnology to industry |
450,00 €
|
| |
| |
Human Cloning: Economics and Ethics
36 pages | Mars 2003 |
Human cloning has moved from science-fiction novels, to science laboratories.
Pro-human cloning companies are racing to create the first cloned child, or make a breakthrough in stem cell research, |
850,00 €
|
| |
| |
03-010: The Market for Toxicogenomics Products & Services
193 pages | Avril 2003 |
This report provides a look at service providers, informatics products, microarrays and databases from the end-user's perspective |
640,00 €
|
| |
| |
04-012: How Life Scientists Buy Products: Implications for Effective Channel Management
303 pages | Mars 2004 |
This report is designed to help suppliers understand how researchers place orders and what drives them to use one method over another |
880,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Nabi Biopharmaceuticals - SWOT Analysis |
|
|
Datamonitor's Nabi Biopharmaceuticals - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Nabi Biopharmaceuticals (Nabi) develops and markets products that target serious medical conditions in the areas of transplantation, infectious disease, nicotine addiction, and hematology/oncology. The company markets Nabi-HB for postexposure prevention of hepatitis B infection and Aloprim for the treatment of chemotherapy-induced hyperuricemia. Nabi is headquartered in Boca Raton, Florida and employs about 650 people. The company recorded revenues of $89.8 million during the fiscal year ended December 2006, a decrease of 4.4% over 2005. The operating loss of the company was $54.2 million during fiscal year 2006, as compared to the operating loss of $109.2 million in 2005. The net loss in fiscal year 2006 was $58.7 million, as compared to the net loss of $128.4 million in 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
Table of Contents:
This product typically includes the following sections:
Key Facts
Company Overview
Business Description
Company History
Key Employees
Key Employee Biographies
Company View
SWOT analysis
Products & Services Listing
Products & Services Analysis
|
|
|
PPLSEN
|
|
|
|
|
